4//SEC Filing
Chondros Dimitrios 4
Accession 0001179110-19-009165
CIK 0001159036other
Filed
Aug 4, 8:00 PM ET
Accepted
Aug 5, 8:11 PM ET
Size
5.0 KB
Accession
0001179110-19-009165
Insider Transaction Report
Form 4
Chondros Dimitrios
SVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2019-08-03$16.70/sh−1,328$22,178→ 38,584 total
Footnotes (1)
- [F1]The reported disposition of 1,328 shares represents the shares that were sold by the reporting person to cover minimum statutory obligations due upon vesting of 3,750 restricted stock award shares.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001739693
Filing Metadata
- Form type
- 4
- Filed
- Aug 4, 8:00 PM ET
- Accepted
- Aug 5, 8:11 PM ET
- Size
- 5.0 KB